GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Vital KSK Holdings Inc (TSE:3151) » Definitions » EV-to-EBITDA

Vital KSK Holdings (TSE:3151) EV-to-EBITDA : 4.04 (As of May. 21, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Vital KSK Holdings EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Vital KSK Holdings's enterprise value is 円35,469 Mil. Vital KSK Holdings's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was 円8,775 Mil. Therefore, Vital KSK Holdings's EV-to-EBITDA for today is 4.04.

The historical rank and industry rank for Vital KSK Holdings's EV-to-EBITDA or its related term are showing as below:

TSE:3151' s EV-to-EBITDA Range Over the Past 10 Years
Min: -0.49   Med: 5.57   Max: 17.96
Current: 4.04

During the past 13 years, the highest EV-to-EBITDA of Vital KSK Holdings was 17.96. The lowest was -0.49. And the median was 5.57.

TSE:3151's EV-to-EBITDA is ranked better than
83.95% of 81 companies
in the Medical Distribution industry
Industry Median: 10.06 vs TSE:3151: 4.04

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-21), Vital KSK Holdings's stock price is 円1200.00. Vital KSK Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was 円114.838. Therefore, Vital KSK Holdings's PE Ratio for today is 10.45.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Vital KSK Holdings EV-to-EBITDA Historical Data

The historical data trend for Vital KSK Holdings's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vital KSK Holdings EV-to-EBITDA Chart

Vital KSK Holdings Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.17 5.52 2.31 3.35 3.24

Vital KSK Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.35 3.96 3.18 2.61 -

Competitive Comparison of Vital KSK Holdings's EV-to-EBITDA

For the Medical Distribution subindustry, Vital KSK Holdings's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vital KSK Holdings's EV-to-EBITDA Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Vital KSK Holdings's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Vital KSK Holdings's EV-to-EBITDA falls into.



Vital KSK Holdings EV-to-EBITDA Calculation

Vital KSK Holdings's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=35468.967/8775
=4.04

Vital KSK Holdings's current Enterprise Value is 円35,469 Mil.
Vital KSK Holdings's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円8,775 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vital KSK Holdings  (TSE:3151) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Vital KSK Holdings's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=1200.00/114.838
=10.45

Vital KSK Holdings's share price for today is 円1200.00.
Vital KSK Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円114.838.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Vital KSK Holdings EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Vital KSK Holdings's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Vital KSK Holdings (TSE:3151) Business Description

Traded in Other Exchanges
N/A
Address
1-1-12 Tsurumaki, Setagaya-ku, JPN, 154-0016
Vital KSK Holdings Inc engaged in the wholesale and retail of pharmaceutical products. It operates through the Pharmaceutical Wholesale and Other segments. The Pharmaceutical Wholesale segment sells medicines, diagnostics, and medical devices to hospitals, medical institutions, and health practitioners. The Other segment includes retail of pharmaceutical products, wholesale of agrochemical and veterinary drugs, transportation, nursing care services, and medical consultancies. All the business activity of the group is primarily functioned through Japan and distributes its product within the Korean and to overseas market.

Vital KSK Holdings (TSE:3151) Headlines

No Headlines